Moderna
MRNA
#290
Rank
C$113.14 B
Marketcap
C$279.63
Share price
-2.17%
Change (1 day)
720.69%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2026 (TTM): C-$11.13

According to Moderna 's latest financial reports the company's current EPS (TTM) is C-$11.46. In 2025 the company made an earnings per share (EPS) of C-$10.43 an increase over its 2024 EPS that were of C-$13.31.

EPS history for Moderna from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$11.136.71%
2025C-$10.43-21.66%
2024C-$13.31-25.04%
2023C-$17.75-158.62%
2022C$30.29-30.25%
2021C$43.42-1660.82%
2020C-$2.7825.32%
2019C-$2.2236.87%
2018C-$1.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.58-183.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.53-165.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$1.42-112.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
C-$1.05-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C-$2.91-74.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$28.41-347.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C-$4.78-58.32%๐Ÿ‡บ๐Ÿ‡ธ USA